Pfizer Will Infringe Hemophilia Patent, Dutch Biotech Claims
Dutch biotech company uniQure has told a London court that Pfizer intends to put a virus-based gene therapy for a rare genetic form of hemophilia on the U.K. market in breach...To view the full article, register now.
Already a subscriber? Click here to view full article